OSTENIL SYRINGE 20MG/2ML

$115.10
No tax

OSTENIL SYRINGE 20MG/2ML

Quantity

 

Security policy (edit with Customer reassurance module)

 

Delivery policy (edit with Customer reassurance module)

 

Return policy (edit with Customer reassurance module)

Indications and usage

Pain and limited mobility in degenerative and traumatic changes in the knee and other synovial joints.

Mechanism of action

Hyaluronic acid (HA) is a natural polymer that provides the viscoelastic properties of synovial fluid. In a normal joint, it has a high concentration on the surface layer of the articular cartilage, as well as on the surface layers of the synovial membrane. In synovial fluid, HAs act as a lubricant and shock absorber, an energy-accumulating agent between cartilage opposite each other, a semi-permeable barrier that regulates metabolic exchanges between cartilage and synovial fluid, an agent that controls cell movement and a viscoelastic screen around synoviocytes and adjacent nerve endings.
A healthy synovial joint is in equilibrium or homeostasis. GC constantly moves in the joint cavity, but its concentration and molecular weight profile remain constant. OSTENIL contains a special fraction of high-purity sodium hyaluronate obtained by bacterial fermentation. The product does not contain animal proteins, which reduces the risk of an allergic reaction, and a narrow molecular weight range helps to ensure that there are no lungs that cause inflammation and hyaluronic acid fragments.

Depending on the size of the joint, inject up to 2 ml of OSTENIL into the joint cavity once a week for 3 to 5 weeks in a row. Several joints can be treated at the same time.

Information about the incompatibility of OSTENIL with other solutions for intra-articular use at this time is missing.

17 Items